Holmes, Christopher P,Yin, Kevin,Lalonde, Guy,Schatz, Peter J,Tumelty, David,Balu, Palani,Zemede, Gemete H
申请号:
NO20055852
公开号:
NO338435B1
申请日:
2005.12.09
申请国别(地区):
NO
年份:
2016
代理人:
摘要:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.